Nature - USA (2020-01-16)

(Antfer) #1
Nature | Vol 577 | 16 January 2020 | 425


  1. Grün, D. & van Oudenaarden, A. Design and analysis of single-cell sequencing
    experiments. Cell 163 , 799–810 (2015).

  2. Stuart, T. & Satija, R. Integrative single-cell analysis. Nat. Rev. Genet. 20 , 257–272 (2019).

  3. Risso, D., Perraudeau, F., Gribkova, S., Dudoit, S. & Vert, J. P. A general and flexible method
    for signal extraction from single-cell RNA-seq data. Nat. Commun. 9 , 284 (2018).

  4. Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by
    pseudotemporal ordering of single cells. Nat. Biotechnol. 32 , 381–386 (2014).

  5. Street, K. et al. Slingshot: cell lineage and pseudotime inference for single-cell
    transcriptomics. BMC Genomics 19 , 477 (2018).

  6. Cheung, T. H. & Rando, T. A. Molecular regulation of stem cell quiescence. Nat. Rev. Mol.
    Cell Biol. 14 , 329–340 (2013).

  7. Oki, T. et al. A novel cell-cycle-indicator, mVenus–p27K−, identifies quiescent cells and
    visualizes G0–G1 transition. Sci. Rep. 4 , 4012 (2014).

  8. Lemmon, M. A. & Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 141 ,
    1117–1134 (2010).

  9. Drosten, M. et al. Genetic analysis of Ras signalling pathways in cell proliferation,
    migration and survival. EMBO J. 29 , 1091–1104 (2010).

  10. Katayama, H. et al. Phosphorylation by aurora kinase A induces Mdm2-mediated
    destabilization and inhibition of p53. Nat. Genet. 36 , 55–62 (2004).

  11. Lim, K. H. et al. Aurora-A phosphorylates, activates, and relocalizes the small GTPase
    RalA. Mol. Cell. Biol. 30 , 508–523 (2010).
    24. Umstead, M., Xiong, J., Qi, Q., Du, Y. & Fu, H. Aurora kinase A interacts with H-Ras and
    potentiates Ras–MAPK signaling. Oncotarget 8 , 28359–28372 (2017).
    25. Gong, X. et al. Aurora A kinase inhibition is synthetic lethal with loss of the RB1 tumor
    suppressor gene. Cancer Discov. 9 , 248–263 (2019).
    26. Donnella, H. J. et al. Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy
    in breast cancer. Nat. Chem. Biol. 14 , 768–777 (2018).
    27. Shah, K. N. et al. Aurora kinase A drives the evolution of resistance to third-generation
    EGFR inhibitors in lung cancer. Nat. Med. 25 , 111–118 (2019).
    28. Keen, N. & Taylor, S. Aurora-kinase inhibitors as anticancer agents. Nat. Rev. Cancer 4 ,
    927–936 (2004).
    29. Sunaga, N. et al. Knockdown of oncogenic KRAS in non-small cell lung cancers
    suppresses tumor growth and sensitizes tumor cells to targeted therapy. Mol. Cancer
    Ther. 10 , 336–346 (2011).
    30. Fakih, M. et al. Phase 1 study evaluating the safety, tolerability, pharmacokinetics (PK), and
    efficacy of AMG 510, a novel small molecule KRASG12C inhibitor, in advanced solid tumors.
    J. Clin. Oncol. 37 , 3003 (2019).
    Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
    published maps and institutional affiliations.
    © The Author(s), under exclusive licence to Springer Nature Limited 2020

Free download pdf